Healthcare integration questions, answered

We help healthcare organisations connect EPR/EMR platforms with departmental and specialist systems. Work can include HL7 v2 and FHIR design, interface-engine configuration, mapping and transformations, testing, go-live preparation, clinical-safety alignment, and ongoing maintenance.

HL7 v2 is a mature messaging standard used for events such as admissions, orders, and results. FHIR uses defined resources and modern API patterns. We help teams choose the right approach, or combine both where the existing hospital landscape requires it, rather than treating one standard as a universal replacement for the other.

Yes. We map the clinical workflow and data exchange between the EPR, departmental systems, and specialist platforms, then design the interfaces, transformations, acknowledgements, and operational ownership needed for a dependable connection.

Yes. We can work with an existing platform such as Mirth Connect, Cloverleaf, or InterSystems HealthShare HealthConnect. The focus is on understandable routing, transformation, monitoring, and support ownership, not on assuming that a platform replacement is required.

It can include message and API inventories, trigger-event decisions, field mappings, transformations, terminology and identifier choices, routing rules, acknowledgements, rejection paths, reconciliation, monitoring, and documentation for delivery and handover.

Testing covers representative and edge-case messages, positive and negative acknowledgements, transformation rules, error handling, end-to-end workflows, and reconciliation against source and target systems. We leave clear evidence and operational steps for investigating exceptions.

We plan cutover around a rehearsed runbook, named decision-makers, validation checks, communications, and a tested rollback route. Hypercare then provides focused monitoring and rapid triage until message flows and clinical workflows are stable in live operation.

Ongoing support can cover monitoring support, incident triage, interface maintenance, root-cause analysis, documentation updates, change-impact reviews, and agreed improvement work. Coverage and response expectations are shaped around your team, systems, and operational ownership; it is not a promise of unlimited capacity or guaranteed response times.

The authenticated, read-only portal provides a concise view of the approved delivery sequence, including milestone phases, integration issues, activity, and go-live documentation surfaces. It is designed as a shared orientation point for the work, not as a live project-management system.

Portal access requires authentication. The portal only displays the approved, scoped delivery information available to the signed-in client, including milestone, issue, activity, and go-live-document views. It does not expose a public project list or unrestricted client data.

We make practical responsibilities visible across the integration: access control, system and environment boundaries, message handling, error paths, operational ownership, change control, monitoring, and handover. The exact controls depend on the systems, data, workflow, and local governance in scope.

No. We do not invent certifications or offer a blanket safety guarantee. We provide technical and clinical-safety alignment inputs, evidence, risks, mitigations, and handover material so the accountable manufacturer, deploying organisation, and local governance stakeholders can make their own informed decisions.

Useful starting information includes the EPR/EMR and departmental systems involved, the clinical or operational workflow, known interface or API specifications, environments, volumes, target dates, current pain points, stakeholders, and any existing safety or governance documentation. A short brief is enough; you do not need a finished design.

We first clarify the systems, workflow, desired outcome, constraints, and decision-makers. From there, the next step may be a focused integration review, a structured discovery session, a delivery conversation, or a clinical-safety discussion. We use the intake to shape a proportionate route rather than presuming a fixed package; timing and response expectations are agreed around the context rather than promised universally.

Yes. Early involvement can help surface interface assumptions, ownership boundaries, message or API choices, testing needs, go-live dependencies, and evidence gaps before they become late delivery problems. We can work from an early brief, procurement question, or known integration risk.

DCB0129 applies where an organisation is acting as the manufacturer of a health IT product or system. We help identify integration-related hazards, requirements, assumptions, mitigations, and evidence that can feed into the manufacturer’s clinical safety case, alongside the appointed Clinical Safety Officer.

DCB0160 supports the deploying organisation’s clinical-safety assessment for using a system in its local context. We can provide integration design details, workflow impacts, test evidence, risks, mitigations, handover material, and change context to help the organisation’s Clinical Safety Officer and governance process make an informed deployment decision.

Yes. We can help organise the technical and safety questions around an EPR/EMR integration, including the evidence expected for testing, deployment, operational ownership, and handover. Our role is alignment guidance and practical delivery input, not procurement approval, legal advice, certification, or a substitute for local clinical-safety accountability.